PubMed Health⌕ Search

PubMed · 12438813

Atrial flutter update.

Abstract

Typical atrial flutter has long been considered a reentrant arrhythmia, but it is only recently that the full structure of the right atrial circuit was understood, leading to de devise of ablation techniques. Recognition of the role of functional block, based on anisotropic conduction was crucial to understanding of the flutter circuit. Anisotropy at the terminal crest creates a line of block that, with the orifices of superior and inferior vena cava, constitutes the posterior boundary of the flutter circuit. The anterior boundary is the tricuspid ring, and the circuit is a ring of myocardium made by the septal and anterior right atrial walls, linked on top by the right atrial roof and inferiorly by the inferior vena cava-tricuspid ring isthmus. This isthmus, a relatively narrow part of the circuit, has become the established target for typical flutter ablation. Complete, bidirectional isthmus block is the final goal of flutter ablation. This has to be assessed, after flutter interruption, by pacing both sides of the ablation line while recording electrogram sequences from the opposite right atrial wall and the isthmus itself. Success is great in terms of prevention of flutter recurrence, however a 30% incidence of atrial fibrillation during follow-up casts a large shadow on long-term prognosis. Understanding of the myocardial abnormalities underlying atrial flutter and fibrillation will be necessary to improve this long-term outlook.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Francisco G Cosío. 2002. Atrial flutter update.. https://doi.org/10.1023/a%3A1021119905261

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.

To prepare weakly basic thrombin inhibitors with modified S1 anchoring groups, two series of compounds were synthesized by reaction of guanidine or aminoguanidine with acyl halides and N,N-disubstituted carbamoyl chlorides. pK(a) measurements of these acylated guanidines/aminoguanidines showed a reduced basicity, with pK(a) values in the range of 8.4-8.7. These molecules typically showed inhibition constants in the range of 150-425 nM against thrombin and 360-965 nM against trypsin, even though some bulky derivatives, such as N,N-diphenylcarbamoylguanidine/aminoguanidine and their congeners, showed much stronger thrombin inhibitory activity, with inhibition constants in the range of 24-42 nM. Unexpectedly, very long incubation times with both proteases revealed that aminoguanidine derivatives behaved as irreversible inhibitors. To assess the molecular basis responsible for the high affinity observed for these molecules toward thrombin, the crystal structure of the thrombin-hirugen-N,N-diphenylcarbamoylaminoguanidine complex has been solved at 1.90 A resolution. The structural analysis of the complex revealed an unexpected interaction mode with the protease, resulting in an N,N-diphenylcarbamoyl intermediate covalently bound to the catalytic serine as a consequence of its hydrolysis together with the release of the aminoguanidine moiety. Surprisingly, in this covalent adduct a phenyl group was found in the S1 specificity pocket, which usually recognizes positively charged residues. These findings provide new insights in the design of low basicity serine protease inhibitors.

Anticoagulants↗